-
N-MYC/eIF4G1 Survival Axis in inv(16) AML
2026-08-17
Peramangalam et al. identify a previously unrecognized MYCN enhancer and establish an N-MYC/eIF4G1 pathway that supports survival in inv(16) acute myeloid leukemia. The study connects CBFβ-SMMHC-dependent transcriptional dysregulation to translational control and provides a mechanistic framework for targeted acute myeloid leukemia research.
-
MK-0812 as a CCR2 Lens on Gut–Liver MASH
2026-08-17
MK-0812 enables precise dissection of CCR2-dependent monocyte recruitment within TM6SF2-driven gut–liver inflammation. This article translates recent MASH findings into assay logic that separates epithelial, lipid, microbial, and immune mechanisms.
-
Hydroxychloroquine Sulfate Workflow Guide
2026-08-16
Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous-compatible tool for examining autophagy pathway modulation and TLR7/9-dependent immune signaling in autoimmune disease research. It is appropriate for short-term water-based workflows, but should not be selected for protocols requiring DMSO or ethanol solubility or long-term storage of prepared solutions.
-
FITC Goat Anti-Mouse IgG (H+L) Antibody
2026-08-15
A scenario-based guide to using the FITC Goat Anti-Mouse IgG (H+L) Antibody, SKU K1201, for reproducible immunofluorescence and flow cytometry readouts in viability, proliferation, and cytotoxicity workflows. It connects assay controls, storage, signal interpretation, and practical reagent-selection criteria to current cell-proliferation evidence.
-
AMG 487: CXCR3 Antagonist Workflow Guide
2026-08-14
AMG 487 provides a selective way to dissect CXCR3 signaling across chemotaxis, calcium flux, macrophage polarization, and inflammatory models. This guide translates its reported potency into practical assay design while highlighting context-dependent biology revealed by the LAMP1–CXCL10–CXCR3 axis.
-
SB 431542: Practical ALK5 Inhibitor Workflows
2026-08-14
SB 431542 is a selective ALK5 inhibitor for separating TGF-β-driven signaling from downstream effects on proliferation, motility, stemness, and immune regulation. This guide translates the reference study into dose-response, Smad2 readouts, CD44 assays, and troubleshooting strategies for reproducible cell-based research.
-
AL-8810: Prostaglandin F2α Antagonist Workflows
2026-08-13
AL-8810 enables receptor-level dissection of PGF2α signaling in endometrial, vascular, ocular, and smooth-muscle models. This workflow guide connects competitive FP receptor antagonism with practical readouts such as ERK1/2 activation, vascular permeability, and MMP-2 secretion.
-
Palonosetron and CINV Prevention: Evidence and Mechanism
2026-08-13
Ruhlmann and Herrstedt review palonosetron hydrochloride as a long-acting 5-HT3 receptor antagonist whose high affinity, allosteric binding, and positive cooperativity may help extend antiemetic activity beyond the acute chemotherapy period. The paper’s practical contribution is a critical comparison of pharmacology, preclinical evidence, clinical trials, and tolerability rather than a simple claim that newer receptor biology automatically produces superior outcomes.
-
Angiotensin II, Cx43, and M1 Macrophage Polarization
2026-08-12
The reference study identifies a connexin 43/NF-κB p65 signaling axis through which Angiotensin II promotes inflammatory M1-like polarization in RAW264.7 macrophages. Its combined inhibitor and multi-assay design links Angiotensin II exposure to cytokine production and macrophage phenotype, while also defining important limits for translation to primary cells and cardiovascular disease models.
-
TAK-242: Practical TLR4 Inhibition Workflows
2026-08-12
TAK-242 (Resatorvid) gives researchers a selective way to interrogate TLR4-driven inflammation, from LPS-stimulated macrophages to microglial responses in heatstroke models. This guide translates the latest cerebral-injury findings into practical assay design, protocol starting points, and troubleshooting strategies.
-
HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody
2026-08-11
Build high-contrast ICC/IF, plaque IHC, flow cytometry, and ELISA workflows around a spectrally defined goat anti-rabbit IgG secondary antibody. The workflow connects ISG20-focused atherosclerosis research with practical controls, multiplexing decisions, and troubleshooting strategies.
-
Maternal IL-17A and Neonatal GBS Risk
2026-08-11
A prospective mother–newborn study in Morocco links reduced maternal IL-17A, IL-1β, and IL-4 responses with invasive Group B Streptococcus disease in newborns. The findings position circulating maternal IL-17A as a promising risk-stratification biomarker and show how ex vivo pathogen-recognition receptor stimulation can complement clinical cytokine profiling.
-
CHIR-99021 (CT99021) in Stem Cell Research
2026-08-10
CHIR-99021, also called CT99021, is a selective glycogen synthase kinase-3 inhibitor used to modulate Wnt/β-catenin signaling in stem-cell workflows. Its reported GSK-3α/β potency and application in vascularized pancreatic progenitor differentiation make it useful for controlled lineage specification, although concentration, timing, and cell context determine outcomes.
-
SB 431542 for EVT TGF-β Signaling Studies
2026-08-09
Use SB 431542 to dissect ALK5-dependent TGF-β responses in primary HLA-G+ extravillous trophoblasts and immune co-cultures. This workflow combines a selective pathway perturbation with the reference study’s two-site EVT isolation strategy, helping distinguish receptor signaling from donor, tissue, and culture effects.
-
Pollen Spectral Interference in Hazardous Aerosol Detection
2026-08-08
Zhang and colleagues developed a fluorescence-spectrum processing workflow to reduce pollen interference during hazardous bioaerosol classification. Using excitation–emission matrix fluorescence spectroscopy, feature transformations, and random forest modeling, fast Fourier transform processing increased reported classification accuracy to 89.24% and improved discrimination of several bacterial and toxin classes.